Eyepoint Pharmaceuticals Inc (EYPT) — Cash Flow-to-Debt Ratio
Eyepoint Pharmaceuticals Inc (EYPT) has a Cash Flow-to-Debt Ratio of -1.15x as of September 2025, meaning its operating cash flow of $-59.35 Million could theoretically repay -1% of its total liabilities ($51.51 Million) in one year. Check Eyepoint Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Eyepoint Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2002–2024)
Historical debt coverage capacity for Eyepoint Pharmaceuticals Inc across 23 annual periods. Also explore Eyepoint Pharmaceuticals Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Eyepoint Pharmaceuticals Inc (2002–2024)
Year-by-year debt coverage analysis for Eyepoint Pharmaceuticals Inc. For market capitalisation and broader financial context, see Eyepoint Pharmaceuticals Inc (EYPT) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.54x | $-126.23 Million | $81.96 Million | ▼ -7398.5% |
| 2023 | 0.02x | $1.88 Million | $88.86 Million | ▲ +102.7% |
| 2022 | -0.77x | $-65.00 Million | $83.99 Million | ▼ -22.0% |
| 2021 | -0.63x | $-50.10 Million | $78.99 Million | ▼ -221.5% |
| 2020 | -0.20x | $-14.44 Million | $73.18 Million | ▲ +77.5% |
| 2019 | -0.88x | $-56.70 Million | $64.64 Million | ▼ -140.2% |
| 2018 | -0.37x | $-21.91 Million | $59.98 Million | ▲ +90.5% |
| 2017 | -3.84x | $-20.49 Million | $5.34 Million | ▼ -152.5% |
| 2016 | -1.52x | $-16.32 Million | $10.74 Million | ▼ -232.8% |
| 2015 | 1.14x | $10.30 Million | $9.00 Million | ▲ +183.1% |
| 2014 | -1.38x | $-10.67 Million | $7.75 Million | ▼ -34.7% |
| 2013 | -1.02x | $-8.74 Million | $8.55 Million | ▲ +20.9% |
| 2012 | -1.29x | $-9.00 Million | $6.96 Million | ▼ -294.9% |
| 2011 | -0.33x | $-3.17 Million | $9.68 Million | ▼ -133.0% |
| 2010 | 0.99x | $9.90 Million | $9.97 Million | ▲ +259.6% |
| 2009 | -0.62x | $-8.44 Million | $13.56 Million | ▼ -110.9% |
| 2008 | -0.29x | $-5.14 Million | $17.44 Million | ▲ +71.9% |
| 2007 | -1.05x | $-21.21 Million | $20.21 Million | ▼ -104.2% |
| 2006 | -0.51x | $-16.14 Million | $31.40 Million | ▲ +91.4% |
| 2005 | -6.01x | $-9.34 Million | $1.56 Million | ▲ +0.0% |
| 2004 | -6.01x | $-9.34 Million | $1.56 Million | ▼ -48.9% |
| 2003 | -4.04x | $-5.44 Million | $1.35 Million | ▲ +22.4% |
| 2002 | -5.20x | $-3.06 Million | $588.38K | — |